selected publications
- Transplant Outcomes in Myelofibrosis: Impact of Donor Type [Cord Blood Grafts Supported by CD34+ selected Cells (Haplo-Cord) vs Matched Donors]. Transplantation and cellular therapy. 2024 Academic Article GET IT
- Haplo-cord transplant. Realizing the potential of umbilical cord blood grafts. - A review of techniques and analysis of outcomes. Leukemia & lymphoma. 2024 Review GET IT
-
XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.
Cancer research.
2024
Academic Article
GET IT
Times cited: 5 - Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation. Bone marrow transplantation. 2023 Letter GET IT
-
Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).
Bone marrow transplantation.
2023
Letter
GET IT
Times cited: 14 - Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation. Transplantation and cellular therapy. 2023 Academic Article GET IT
- Pre-hematopoietic stem cell transplant rituximab for Epstein-Barr Virus and post-transplant lymphoproliferative disorder prophylaxis in alemtuzumab recipients. Transplantation and cellular therapy. 2022 Academic Article GET IT
-
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation.
Transplantation and cellular therapy.
2022
Academic Article
GET IT
Times cited: 11 -
C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Bone marrow transplantation.
2022
Letter
GET IT
Times cited: 1 -
Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes.
Leukemia & lymphoma.
2021
Academic Article
GET IT
Times cited: 1 -
Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2021
Academic Article
GET IT
Times cited: 32 -
Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma.
Leukemia & lymphoma.
2021
Academic Article
GET IT
Times cited: 1 -
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response.
Blood advances.
2020
Academic Article
GET IT
Times cited: 5 -
Clinical Screening for COVID-19 in Asymptomatic Patients With Cancer.
JAMA network open.
2020
Academic Article
GET IT
Times cited: 20 -
Hematology and oncology clinical care during the coronavirus disease 2019 pandemic.
CA: a cancer journal for clinicians.
2020
Academic Article
GET IT
Times cited: 18 -
Poor graft function after T cell-depleted allogeneic hematopoietic stem cell transplant.
Leukemia & lymphoma.
2020
Academic Article
GET IT
Times cited: 1 -
Impact of alemtuzumab dosing and low-dose total body irradiation on cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation.
Leukemia & lymphoma.
2020
Letter
GET IT
Times cited: 2 -
Cord blood transplants supported by unrelated donor CD34+ progenitor cells.
Bone marrow transplantation.
2020
Academic Article
GET IT
Times cited: 3 -
Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic Malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2019
Academic Article
GET IT
Times cited: 5 -
Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning.
Blood advances.
2019
Academic Article
GET IT
Times cited: 29 -
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.
Bone marrow transplantation.
2019
Academic Article
GET IT
Times cited: 12 -
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk.
Leukemia & lymphoma.
2019
Academic Article
GET IT
Times cited: 11 -
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2018
Academic Article
GET IT
Times cited: 2 -
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2018
Academic Article
GET IT
Times cited: 5 -
Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.
Blood advances.
2018
Academic Article
GET IT
Times cited: 26 -
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 11 -
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 24 -
Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 15 -
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2017
Academic Article
GET IT
Times cited: 7 -
The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies.
Transplantation.
2017
Academic Article
GET IT
Times cited: 10 -
Second allogeneic transplantation: ever? never? or sometimes.
Leukemia & lymphoma.
2016
Comment
GET IT
Times cited: 1 -
Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
Annals of the American Thoracic Society.
2016
Academic Article
GET IT
Times cited: 71 -
Haplo-cord transplant: HLA-matching determines graft dominance.
Leukemia & lymphoma.
2016
Letter
GET IT
Times cited: 9 -
Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.
Blood.
2016
Academic Article
GET IT
Times cited: 39 -
Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period.
Leukemia & lymphoma.
2016
Academic Article
GET IT
Times cited: 21 -
Cord blood chimerism and relapse after haplo-cord transplantation.
Leukemia & lymphoma.
2016
Academic Article
GET IT
Times cited: 19 -
Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation.
Leukemia & lymphoma.
2016
Academic Article
GET IT
Times cited: 10 -
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2016
Academic Article
GET IT
Times cited: 17 -
Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment.
Clinical lymphoma, myeloma & leukemia.
2016
Academic Article
GET IT
Times cited: 10 -
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
Haematologica.
2016
Academic Article
GET IT
Times cited: 36 -
Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2015
Academic Article
GET IT
Times cited: 127 -
Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2015
Academic Article
GET IT
Times cited: 13 -
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2015
Academic Article
GET IT
Times cited: 151 -
A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2015
Academic Article
GET IT
Times cited: 68 -
Human herpesvirus 6 infection in a bone marrow biopsy specimen after allogeneic stem cell transplantation.
British journal of haematology.
2015
Academic Article
GET IT
Times cited: 1 -
A strategy to reduce donor-specific HLA Abs before allogeneic transplantation.
Bone marrow transplantation.
2014
Letter
GET IT
Times cited: 10 -
A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2013
Academic Article
GET IT
Times cited: 12 -
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2013
Academic Article
GET IT
Times cited: 30 -
Are low-intensity induction strategies better for older patients with acute myeloid leukemia?.
Leukemia research.
2012
Academic Article
GET IT
Times cited: 8 -
Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML.
Blood.
2011
Academic Article
GET IT
Times cited: 118 -
Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies.
The Mount Sinai journal of medicine, New York.
2005
Information Resource
GET IT
Times cited: 32 -
Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain.
Molecular cell.
2003
Academic Article
GET IT
Times cited: 189 -
Influence of drugs on myocardial iodine-123 metaiodobenzylguanidine uptake in rabbit myocardium.
European journal of nuclear medicine.
2000
Academic Article
GET IT
Times cited: 9